Lake Street Capital began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a research report report published on Wednesday morning, MarketBeat.com reports. The firm issued a buy rating and a $20.00 target price on the stock.
AVR has been the subject of several other reports. Cantor Fitzgerald assumed coverage on Anteris Technologies Global in a report on Tuesday. They issued an “overweight” rating and a $9.00 target price for the company. TD Cowen assumed coverage on Anteris Technologies Global in a report on Tuesday. They issued a “buy” rating and a $15.00 target price for the company. Finally, Barclays assumed coverage on Anteris Technologies Global in a report on Tuesday. They issued an “overweight” rating and a $22.00 target price for the company.
Get Our Latest Stock Report on Anteris Technologies Global
Anteris Technologies Global Trading Up 6.6 %
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Further Reading
- Five stocks we like better than Anteris Technologies Global
- Most Volatile Stocks, What Investors Need to Know
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How Can Investors Benefit From After-Hours Trading
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
